These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9432837)

  • 1. [The immunosuppressive action of different fractions of Salmonella typhimurium lipopolysaccharide].
    Borisova EV; Bondarenko VM; Molozhavaia OS; Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):120-3. PubMed ID: 9432837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunosuppressive components of extracellular lipopolysaccharide highly virulent strain Salmonella typhimurium 1468].
    Molozhavaia OS; Borisova EV
    Mikrobiol Z; 2002; 64(3):75-80. PubMed ID: 12190039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immunosuppressive activity of filtrates of the culture broth from nonvirulent salmonellae].
    Molozhavaia OS; Borisova EV; Borisov VA
    Mikrobiol Z; 1997; 59(2):73-8. PubMed ID: 9221061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dependence of immunosuppressive action of lipopolysaccharide on degree of Salmonella pathogenicity].
    Borisova EV; Bondarenko VM; Molozhavaia OS; Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (1):40-3. PubMed ID: 11236501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immunosuppressive activity of Shigella sonnei differing by the presence of plasmid pSS120].
    Borisova EV; Bondarenko VM; Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (6):65-8. PubMed ID: 9460870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppressive action of lipopolysaccharide S- and R-forms of Salmonella and the role of lipid A].
    Borisova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (6):20-3. PubMed ID: 9949494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The inductive immunosuppressive activity of the lipopolysaccharide from Shigella sonnei R forms].
    Borisova EV
    Mikrobiol Z; 1998; 60(3):63-9. PubMed ID: 9785801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of the structural components of bacterial lipopolysaccharide in its inductive immunosuppressive activity].
    Borisova EV
    Mikrobiol Z; 1999; 61(6):36-41. PubMed ID: 10707531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
    Colwell DE; Michalek SM; Briles DE; Jirillo E; McGhee JR
    J Immunol; 1984 Aug; 133(2):950-7. PubMed ID: 6203984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Components with potential immunosuppressive activity in lipopolysaccharide of laboratory Pseudomonas aeruginosa strains.
    Vikström EV
    Immunol Lett; 2003 Jan; 85(1):29-33. PubMed ID: 12505193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection and immune responses induced by attenuated Salmonella typhimurium UK-1 strains.
    Zhang X; Kelly SM; Bollen W; Curtiss R
    Microb Pathog; 1999 Mar; 26(3):121-30. PubMed ID: 10089152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immunomodulating properties of the filtrates of Klebsiella culture broth and the nature of the immunomodulating factor].
    Borisova EV; Polishchuk EI; Sel'nikova OP; Mishina LN; Borisov VA
    Mikrobiol Z; 1996; 58(6):55-62. PubMed ID: 9064073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunosuppressive components of extracellular polysaccharide from Pseudomonas aeruginosa clinical strains].
    Borisova EV
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (6):35-8. PubMed ID: 11210632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of the structural parts of bacterial lipopolysaccharide in its direct immunosuppressive activity].
    Borisova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (2):22-5. PubMed ID: 10356729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed (footpad) hypersensitivity and Arthus reactivity using protein-rich antigens and LPS in mice immunized with live attenuated aroA Salmonella vaccines.
    Mastroeni P; Villarreal-Ramos B; Demarco de Hormaeche R; Hormaeche CE
    Microb Pathog; 1993 May; 14(5):369-79. PubMed ID: 8366814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunosuppressive activity of chemically modified lipopolysaccharide of Shigella sonnei.
    Vikström EV
    Immunol Lett; 2002 Jan; 80(1):15-9. PubMed ID: 11716960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protein-lipopolysaccharide complex extracted with trichloracetic acid from Salmonella typhimurium effective in protection of mice against S. typhimurium infection.
    Plant JE; Wilson BM; Glynn AA
    Parasite Immunol; 1982 Jul; 4(4):259-71. PubMed ID: 6750510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The inductive immunosuppressive activity of the nonspecific lipopolysaccharide fraction of virulent Shigella sonnei].
    Borisova EV; Borisov VA
    Mikrobiol Z; 1997; 59(1):77-81. PubMed ID: 9172868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
    McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen.
    Hormaeche CE; Mastroeni P; Harrison JA; Demarco de Hormaeche R; Svenson S; Stocker BA
    Vaccine; 1996 Mar; 14(4):251-9. PubMed ID: 8744548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.